Table A1.
Summary of the number and proportion of tissues labeled with different antibodies.
| Samples Stained | NTPDase1 (CD39) | NTPDase2 | NTPDase3 | NPP3 | 5′-NT (CD73) | CD26 |
|---|---|---|---|---|---|---|
| Positive Cases/Total of Samples (% of Tissues Stained) | ||||||
| Eutopic endometrium | ||||||
| Surface epithelium | 1/14 (7.1%) | 14/14 (100%) | 7/13 (53.8%) | 12/13 (92.3%) | 9/12 (75%) | 7/14 (50%) |
| Glandular epithelium | 1/20 (5%) | 20/20 (100%) | 16/20 (80%) | 18/19 (94.7%) | 20/20 (100%) | 15/20 (75%) |
| Endometrial stromal cells | 7/20 (35%) | 20/20 (100%) | 0/20 (0%) | 15/19 (78.9%) | 12/20 (60%) | 0/20 (0%) |
| Spiral arteries | 19/20 (95%) | 3/20 (15%) | 5/20 (25%) | 16/18 (88.9%) | 3/20 (15%) | 3/19 (15.8%) |
| Peritoneal endometriosis | ||||||
| Endometrial epithelial cells | 1/7 (14.3%) | 7/7 (100%) | 7/7 (100%) | 7/7 (100%) | 5/7 (71.4%) | 4/7 (57.1%) |
| Endometrial stromal cells | 6/7 (85.7%) | 7/7 (100%) | 0/7 (0%) | 7/7 (100%) | 5/7 (71.4%) | 2/7 (28.6%) |
| Vessels of the lesion | 5/7 (71.4%) | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) | 1/7 (14.28%) | 0/7 (0%) |
| Ovarian endometriosis | ||||||
| Endometrial epithelial cells | 8/28 (28.6%) | 20/28 (71.4%) | 16/28 (57.1%) | 24/28 (85.7%) | 24/28 (85.7%) | 19/28 (67.9%) |
| Endometrial stromal cells | 16/27 (59.3%) | 10/27 (37%) | 3/27 (11.1%) | 16/27 (59.3%) | 13/27 (48.1%) | 2/27 (7.4%) |
| Vessels of the lesion | 23/28 (82.1%) | 1/28 (3.6%) | 2/28 (7.1%) | 8/28 (28.6%) | 3/28 (10.7%) | 3/28 (10.7%) |
| Deep endometriosis | ||||||
| Endometrial epithelial cells | 6/28 (21.4%) | 23/26 (88.5%) | 12/27 (44.4%) | 24/28 (85.7%) | 17/28 (60.7%) | 15/28 (53.6%) |
| Endometrial stromal cells | 9/25 (36%) | 17/26 (65.4%) | 1/27 (3.7%) | 18/27 (66.7%) | 6/27 (22.2%) | 1/27 (3.7%) |
| Vessels of the lesion | 11/24 (45.8%) | 5/25 (20%) | 1/27 (3.7%) | 7/27 (25.9%) | 7/27 (25.9%) | 0/27 (0%) |